- Home
- BLCO vs PFSI Comparison
BLCO vs PFSI Comparison
Compare BLCO & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- PFSI
- Stock Information
- Founded
- BLCO 1853
- PFSI 2008
- Country
- BLCO Canada
- PFSI United States
- Employees
- BLCO N/A
- PFSI N/A
- Industry
- BLCO Ophthalmic Goods
- PFSI Finance: Consumer Services
- Sector
- BLCO Health Care
- PFSI Finance
- Exchange
- BLCO Nasdaq
- PFSI Nasdaq
- Market Cap
- BLCO 4.9B
- PFSI 5.4B
- IPO Year
- BLCO 2022
- PFSI 2013
- Fundamental
- Price
- BLCO $15.23
- PFSI $124.52
- Analyst Decision
- BLCO Hold
- PFSI Buy
- Analyst Count
- BLCO 11
- PFSI 7
- Target Price
- BLCO $15.80
- PFSI $120.14
- AVG Volume (30 Days)
- BLCO 492.5K
- PFSI 413.9K
- Earning Date
- BLCO 10-29-2025
- PFSI 10-21-2025
- Dividend Yield
- BLCO N/A
- PFSI 0.96%
- EPS Growth
- BLCO N/A
- PFSI 97.42
- EPS
- BLCO N/A
- PFSI 7.22
- Revenue
- BLCO $4,891,000,000.00
- PFSI $3,571,340,000.00
- Revenue This Year
- BLCO $8.27
- PFSI N/A
- Revenue Next Year
- BLCO $5.73
- PFSI $23.52
- P/E Ratio
- BLCO N/A
- PFSI $17.25
- Revenue Growth
- BLCO 8.81
- PFSI 65.89
- 52 Week Low
- BLCO $10.45
- PFSI $85.74
- 52 Week High
- BLCO $21.69
- PFSI $127.56
- Technical
- Relative Strength Index (RSI)
- BLCO 59.83
- PFSI 79.02
- Support Level
- BLCO $15.00
- PFSI $107.48
- Resistance Level
- BLCO $15.50
- PFSI $127.56
- Average True Range (ATR)
- BLCO 0.34
- PFSI 2.86
- MACD
- BLCO 0.02
- PFSI 1.07
- Stochastic Oscillator
- BLCO 72.03
- PFSI 84.86
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.